STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Janus Henderson Reports 5,378,185 Shares, 3.6% Stake in 89bio

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Janus Henderson Group plc reports beneficial ownership of 5,378,185 shares of 89bio, Inc. common stock, representing 3.6% of the class, with shared voting and dispositive power reported. The filing also discloses that an indirect subsidiary, JHIUS, may be deemed the beneficial owner of 5,052,254 shares, or 3.4%, all held with shared voting and dispositive authority. The filing classifies the reporting person as an investment adviser and holding company and includes a power of attorney authorizing designated compliance officers to file required ownership reports. No holdings exceeding 5% of the class are reported and the statement affirms the securities are held in the ordinary course of business and not to influence control.

Positive

  • Transparent disclosure of aggregate ownership at 3.6% (5,378,185 shares)
  • Subsidiary ownership detail provided: JHIUS beneficial owner of 5,052,254 shares (3.4%)
  • Certification states holdings are in the ordinary course of business, not for control purposes

Negative

  • No holdings exceed 5%, so this position is unlikely to trigger enhanced shareholder influence
  • Shared voting/dispositive power only, limiting clarity on direct control over votes or dispositions

Insights

Large institutional stake below 5% signals passive investment exposure.

Janus Henderson Group plc holds 5,378,185 shares, equal to 3.6% of the outstanding class, recorded with shared voting and dispositive power. The disclosure shows position-level detail including a subsidiary (JHIUS) ownership of 5,052,254 shares (3.4%), which explains part of the aggregate.

The holding is material enough to warrant monitoring but does not meet the >5% threshold that typically triggers greater regulatory or market scrutiny. Watch subsequent amendment filings for changes in stake size or shifts from shared to sole voting/dispositive power over the next reporting periods.

Filing follows Schedule 13G format and affirms ordinary-course investment intent.

The statement classifies the filer under investment adviser and holding company types and includes a certification that the securities are held in the ordinary course of business and not to change control. It also attaches a power of attorney that authorizes compliance officers to make future ownership filings.

Investors should note the certification language and the existence of delegated filing authority; any future amendments that change the stated intent or the nature of voting/dispositive power would be the concrete signals to monitor in subsequent filings.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



JANUS HENDERSON GROUP PLC
Signature:Kristin Mariani
Name/Title:Head of North America Compliance, CCO
Date:10/07/2025
Exhibit Information

POWER OF ATTORNEY The undersigned, Janus Henderson Group plc ("the Company"), does hereby make, constitute and appoint each of Kristin Mariani and Caroline Barotti acting severally, as its true and lawful attorneys in-fact, for the purpose of, from time to time, executing in its name and on its behalf, whether the Company individually or as representative of others, any and all documents, certificates, instruments, statements, other filings and amendments to the foregoing (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including, without limitation, Forms 13D, 13F, 13G and 13H and any amendments to any of the foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental, regulatory authority or other person, and giving and granting to each such attorney-in-fact power and authority to act in the premises as fully and to all intents and purposes as the Company might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 9th day of December, 2022. Janus Henderson Group plc By: /s/ Michelle Rosenberg Name: Michelle Rosenberg Title: General Counsel and Company Secretary

FAQ

What stake does Janus Henderson report in 89bio (ETNB)?

Janus Henderson Group plc reports beneficial ownership of 5,378,185 shares, equal to 3.6% of 89bio's common stock.

Does Janus Henderson control the 89bio shares it reports?

The filing reports shared voting and shared dispositive power over the shares, not sole control, and states the holdings are in the ordinary course of business.

Is any subsidiary identified as owning 89bio shares?

Yes. An indirect subsidiary, JHIUS, may be deemed the beneficial owner of 5,052,254 shares (3.4%), held with shared voting and dispositive authority.

Does this filing indicate an intent to change control of 89bio?

No. The document includes a certification that the securities were not acquired and are not held for the purpose of changing or influencing control.

Who signed the filing on behalf of Janus Henderson?

The filing is signed by Kristin Mariani in her capacity as Head of North America Compliance, CCO.
89Bio, Inc.

NASDAQ:ETNB

ETNB Rankings

ETNB Latest News

ETNB Latest SEC Filings

ETNB Stock Data

2.20B
147.57M
0.54%
111.85%
11.05%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN FRANCISCO